194 related articles for article (PubMed ID: 20500856)
21. Molecular characterization of Plasmodium falciparum uracil-DNA glycosylase and its potential as a new anti-malarial drug target.
Suksangpleng T; Leartsakulpanich U; Moonsom S; Siribal S; Boonyuen U; Wright GE; Chavalitshewinkoon-Petmitr P
Malar J; 2014 Apr; 13():149. PubMed ID: 24742318
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.
Parquet V; Henry M; Wurtz N; Dormoi J; Briolant S; Gil M; Baret E; Amalvict R; Rogier C; Pradines B
Malar J; 2010 May; 9():139. PubMed ID: 20497586
[TBL] [Abstract][Full Text] [Related]
23. Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs.
Foguim FT; Robert MG; Gueye MW; Gendrot M; Diawara S; Mosnier J; Amalvict R; Benoit N; Bercion R; Fall B; Madamet M; Pradines B;
Malar J; 2019 Aug; 18(1):293. PubMed ID: 31455301
[TBL] [Abstract][Full Text] [Related]
24. Partial characterization of Plasmodium falciparum trophozoite proteome under treatment with quinine, mefloquine and the natural antiplasmodial diosgenone.
Segura C; Cuesta-Astroz Y; Nunes-Batista C; Zalis M; von Krüger WM; Mascarello Bisch P
Biomedica; 2014; 34(2):237-49. PubMed ID: 24967929
[TBL] [Abstract][Full Text] [Related]
25. Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria.
Ali F; Wali H; Jan S; Zia A; Aslam M; Ahmad I; Afridi SG; Shams S; Khan A
Malar J; 2021 Aug; 20(1):335. PubMed ID: 34344361
[TBL] [Abstract][Full Text] [Related]
26. A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.
Penarete-Vargas DM; Boisson A; Urbach S; Chantelauze H; Peyrottes S; Fraisse L; Vial HJ
PLoS One; 2014; 9(12):e113918. PubMed ID: 25470252
[TBL] [Abstract][Full Text] [Related]
27. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
[TBL] [Abstract][Full Text] [Related]
28. Use of variability in the stage-specific transcription levels of Plasmodium falciparum in the selection of target genes.
Kumar VP; Datta S
Parasitol Int; 2001 Sep; 50(3):165-73. PubMed ID: 11595573
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in malaria genomics and epigenomics.
Kirchner S; Power BJ; Waters AP
Genome Med; 2016 Sep; 8(1):92. PubMed ID: 27605022
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia.
Dwivedi A; Reynes C; Kuehn A; Roche DB; Khim N; Hebrard M; Milanesi S; Rivals E; Frutos R; Menard D; Mamoun CB; Colinge J; Cornillot E
Malar J; 2017 Dec; 16(1):493. PubMed ID: 29258508
[TBL] [Abstract][Full Text] [Related]
31. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA
Malar J; 2010 Jun; 9():181. PubMed ID: 20573274
[TBL] [Abstract][Full Text] [Related]
32. Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking.
Kennedy K; Cobbold SA; Hanssen E; Birnbaum J; Spillman NJ; McHugh E; Brown H; Tilley L; Spielmann T; McConville MJ; Ralph SA
PLoS Biol; 2019 Jul; 17(7):e3000376. PubMed ID: 31318858
[TBL] [Abstract][Full Text] [Related]
33. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
[TBL] [Abstract][Full Text] [Related]
34. Artemisinin antimalarials: mechanisms of action and resistance.
Meshnick SR
Med Trop (Mars); 1998; 58(3 Suppl):13-7. PubMed ID: 10212891
[TBL] [Abstract][Full Text] [Related]
35. Identification and localization of a Novel Invasin of Plasmodium falciparum.
Hans N; Relan U; Dubey N; Gaur D; Chauhan VS
Mol Biochem Parasitol; 2015 Aug; 202(2):38-43. PubMed ID: 26431890
[TBL] [Abstract][Full Text] [Related]
36. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
37. Artemisinin Action and Resistance in Plasmodium falciparum.
Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
[TBL] [Abstract][Full Text] [Related]
38. The chromatin bound proteome of the human malaria parasite.
Batugedara G; Lu XM; Saraf A; Sardiu ME; Cort A; Abel S; Prudhomme J; Washburn MP; Florens L; Bunnik EM; Le Roch KG
Microb Genom; 2020 Feb; 6(2):. PubMed ID: 32017676
[TBL] [Abstract][Full Text] [Related]
39. Genetic ablation of the mitoribosome in the malaria parasite
Ling L; Mulaka M; Munro J; Dass S; Mather MW; Riscoe MK; Llinás M; Zhou J; Ke H
J Biol Chem; 2020 May; 295(21):7235-7248. PubMed ID: 32273345
[TBL] [Abstract][Full Text] [Related]
40. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.
Chavchich M; Gerena L; Peters J; Chen N; Cheng Q; Kyle DE
Antimicrob Agents Chemother; 2010 Jun; 54(6):2455-64. PubMed ID: 20350946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
